Patents Assigned to Shenyang Pharmaceutical University
  • Publication number: 20100022656
    Abstract: The invention provides compounds of formula (I) having (?) or (+) configuration, or pharmaceutically acceptable salts thereof, wherein R1 is H or halo; R2 is CF3, CN, or halo; R3 is linear or branched alkyl having 1 to 6 carbon atoms, or cycloalkyl having 3 to 6 carbon atoms. The invention also relates to methods for preparing the said compounds and the composition comprising the same. The compounds of the present invention have the effect of ?2-receptor agonist and can be used for the treatment of asthma or bronchitis.
    Type: Application
    Filed: July 2, 2007
    Publication date: January 28, 2010
    Applicant: SHENYANG PHARMACEUTICAL UNIVERSITY
    Inventors: Maosheng Cheng, Li Pan, Dongkai Wang, Ruijuan Xing, Xuyao Chen, Dongmei Zhao
  • Patent number: 7592309
    Abstract: The present invention relates to a peptide having analgesic and antitumor activity derived from the scorpion and partial fragment, derivative or analogue thereof having analgesic and antitumor activity, and preparation method and use thereof. The peptide having analgesic and antitumor activity is obtained by extraction, isolation and purification from the scorpion or scorpion venom. The peptide having analgesic and antitumor activity derived from the scorpion and partial fragment, derivative or analogue thereof can be obtained by chemical synthesis method or bioengineering method. The peptide having analgesic and antitumor activity derived from the scorpion and partial fragment, derivative or analogue thereof is used as the analgesic and antitumor drugs.
    Type: Grant
    Filed: September 29, 2002
    Date of Patent: September 22, 2009
    Assignee: Shenyang Pharmaceutical University
    Inventors: Jinghai Zhang, Runlin Ma, Siling Wang, Yanfeng Liu, Chunfu Wu
  • Patent number: 7098364
    Abstract: The invention provides compounds of formula (I) and pharmaceutically acceptable salts thereof, wherein R1 is H, chlorine, or bromine; R2 is electron attractive groups selected from the group consisting of CF3, CN, fluorine, CH3SO3, CF3SO3, and NO2; R3 is linear or branched alkyl having 1 to 10 carbon atoms, linear or branched alkoxyalkyl having 2 to 10 carbon atoms, aliphatic alcohol having 1 to 10 carbon atoms, or cycloalkyl having 3 to 6 carbon atoms. The invention also relates to methods for preparing the said compounds and the composition comprising the same.
    Type: Grant
    Filed: September 25, 2002
    Date of Patent: August 29, 2006
    Assignees: Shenyang Pharmaceutical University, Jinzhou Jiutai Pharmaceutical Co., Ltd., China
    Inventors: Maosheng Cheng, Li Pan, Lie Ji, Li Zhang, Jianmin Shen, Guilan Song, Zhiging Li